BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36867284)

  • 1. Increased α-2,6 sialic acid on microglia in amyloid pathology is resistant to oseltamivir.
    Fastenau C; Wickline JL; Smith S; Odfalk KF; Solano L; Bieniek KF; Hopp SC
    Geroscience; 2023 Jun; 45(3):1539-1555. PubMed ID: 36867284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution.
    Rameix-Welti MA; Munier S; Le Gal S; Cuvelier F; Agou F; Enouf V; Naffakh N; van der Werf S
    Antivir Ther; 2011; 16(4):597-603. PubMed ID: 21685548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide activates microglia via neuraminidase 1 desialylation of Toll-like Receptor 4.
    Allendorf DH; Franssen EH; Brown GC
    J Neurochem; 2020 Nov; 155(4):403-416. PubMed ID: 32279315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
    Katorcha E; Klimova N; Makarava N; Savtchenko R; Pan X; Annunziata I; Takahashi K; Miyagi T; Pshezhetsky AV; d'Azzo A; Baskakov IV
    PLoS One; 2015; 10(11):e0143218. PubMed ID: 26569607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialidase Inhibitors with Different Mechanisms.
    Keil JM; Rafn GR; Turan IM; Aljohani MA; Sahebjam-Atabaki R; Sun XL
    J Med Chem; 2022 Oct; 65(20):13574-13593. PubMed ID: 36252951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.
    Pshezhetsky AV; Hinek A
    Glycoconj J; 2011 Oct; 28(7):441-52. PubMed ID: 21928149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
    Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H
    J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A secondary sialic acid binding site on influenza virus neuraminidase: fact or fiction?
    Lai JC; Garcia JM; Dyason JC; Böhm R; Madge PD; Rose FJ; Nicholls JM; Peiris JS; Haselhorst T; von Itzstein M
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2221-4. PubMed ID: 22281708
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
    Hitaoka S; Harada M; Yoshida T; Chuman H
    J Chem Inf Model; 2010 Oct; 50(10):1796-805. PubMed ID: 20863103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.
    Ming M; Chuenkova M; Ortega-Barria E; Pereira ME
    Mol Biochem Parasitol; 1993 Jun; 59(2):243-52. PubMed ID: 8341323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sialic acids in feline enteric coronavirus infections.
    Desmarets LMB; Theuns S; Roukaerts IDM; Acar DD; Nauwynck HJ
    J Gen Virol; 2014 Sep; 95(Pt 9):1911-1918. PubMed ID: 24876305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialidases from gut bacteria: a mini-review.
    Juge N; Tailford L; Owen CD
    Biochem Soc Trans; 2016 Feb; 44(1):166-75. PubMed ID: 26862202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.
    de Oliveira Formiga R; Amaral FC; Souza CF; Mendes DAGB; Wanderley CWS; Lorenzini CB; Santos AA; Antônia J; Faria LF; Natale CC; Paula NM; Silva PCS; Fonseca FR; Aires L; Heck N; Starick MR; Queiroz-Junior CM; Santos FRS; de Souza FRO; Costa VV; Barroso SPC; Morrot A; Van Weyenbergh J; Sordi R; Alisson-Silva F; Cunha FQ; Rocha EL; Chollet-Martin S; Hurtado-Nedelec MM; Martin C; Burgel PR; Mansur DS; Maurici R; Macauley MS; Báfica A; Witko-Sarsat V; Spiller F
    Br J Pharmacol; 2023 Jun; 180(11):1460-1481. PubMed ID: 36526272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
    Triana-Baltzer GB; Gubareva LV; Klimov AI; Wurtman DF; Moss RB; Hedlund M; Larson JL; Belshe RB; Fang F
    PLoS One; 2009 Nov; 4(11):e7838. PubMed ID: 19893749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
    Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
    PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells.
    Teuton JR; Brandt CR
    J Virol; 2007 Apr; 81(8):3731-9. PubMed ID: 17229687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The participation of sialic acids in microglia-neuron interactions.
    Wielgat P; Braszko JJ
    Cell Immunol; 2012; 273(1):17-22. PubMed ID: 22209424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylation: an Avenue to Target Cancer Cells.
    Vajaria BN; Patel KR; Begum R; Patel PS
    Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir.
    Tai SH; Agafitei O; Gao Z; Liggins R; Petric M; Withers SG; Niikura M
    Virus Res; 2015 Dec; 210():126-32. PubMed ID: 26247418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.